Investments
3Portfolio Exits
2New China Capital Investments
3 Investments
New China Capital has made 3 investments. Their latest investment was in Tianchen Biomedical as part of their Series A on January 1, 2021.
New China Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
1/5/2021 | Series A | Tianchen Biomedical | $15.49M | Yes | 3 | |
1/1/2019 | Series A | |||||
9/17/2015 | Series B |
Date | 1/5/2021 | 1/1/2019 | 9/17/2015 |
|---|---|---|---|
Round | Series A | Series A | Series B |
Company | Tianchen Biomedical | ||
Amount | $15.49M | ||
New? | Yes | ||
Co-Investors | |||
Sources | 3 |
New China Capital Portfolio Exits
2 Portfolio Exits
New China Capital has 2 portfolio exits. Their latest portfolio exit was Sanbum Optoelectronics on June 20, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
6/20/2022 | IPO | 1 | |||
Date | 6/20/2022 | |
|---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | ||
Sources | 1 |
New China Capital Acquisitions
1 Acquisition
New China Capital acquired 1 company. Their latest acquisition was Louis Dreyfus - Metals on May 11, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/11/2018 | Acquired Unit - Fin | 1 |
Date | 5/11/2018 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired Unit - Fin |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.